#2006-1640Law on the Financing of Social Security for 2007
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law outlines how France is handling deficits and surpluses in its social security system for 2007. It discusses covering deficits, particularly in health and retirement funds, using methods like debt amortization and restructuring loans. Pharmaceutical companies will face an exceptional contribution based on their 2006 sales in France.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Deficits in health and retirement funds addressed through debt amortization
- Introduction of an exceptional contribution for pharmaceutical companies based on 2006 sales
- Adjustments to social security contributions and taxes
Obligations
What this law requires
CADES must cover cumulative deficits of the Maladie branch as of December 31, 2003 and the projected deficit for 2004 up to a global limit of 35 billion euros, and cover projected deficits for 2005 and 2006 up to a global limit of 15 billion euros
ACOSS must cover deficits of the Vieillesse, Famille, and Accidents du travail - maladies professionnelles branches through treasury loans from the Caisse des dépôts et consignations, within limits of 13 billion euros for 2005 and 18.5 billion euros for 2006
FFIPSA must finance its 2005 deficit of 1.4 billion euros through treasury loans from the CALYON consortium, within the limit of 6.2 billion euros for 2005 and 7.1 billion euros for 2006
Pharmaceutical companies must pay an exceptional contribution based on their 2006 sales in France
Health insurance regimes must record and transfer ONDAM médico-social amounts as charges to CNSA starting from 2006, and record corresponding reimbursements from CNSA as income